# ARGOBIO

> ARGOBIO is a VC fund in Paris backing Medical and Biotechnology. See 4 investments, check sizes, portfolio and contact details. Updated Aug 2026.

- Type: VC Fund
- Location: Paris, France
- Total investments: 4
- Last investment: Mar 2026
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/company/argobio/
- Website: https://www.argobiostudio.com/

Argobio is a start-up studio devoted to developing unique therapeutic solutions, with the purpose of nurturing and launching revolutionary biotech firms. It sources cutting-edge early-stage projects from leading European academic research institutes in order to cultivate and nurture these projects before launching companies. The main focus is onrare diseases, neurological issues, oncology, and immunology. Additionally, the studio is looking to create promising platform technologies for therapeutic products.

## Contacts

5 contacts available for ARGOBIO. Shizune tracks 4 team members at ARGOBIO. Sign up free to unlock them: https://app.shizune.co/sign-up/investor-profiles/find-team-emails/argobio?utm_source=investor_profile

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Medical | 3 | 75% |
| Biotechnology | 3 | 75% |
| Health Care | 2 | 50% |
| Therapeutics | 1 | 25% |

### Country

| Country | Investments | Share |
| --- | --- | --- |
| France | 2 | 50% |
| The Netherlands | 1 | 25% |

## Team

| Name | Title | Investments | Profile |
| --- | --- | --- | --- |
| Daniel Sobral | Partner and Chief Financial Officer | 0 | https://shizune.co/investors/profile/daniel-sobral-a639 |
| Neill Moray Mackenzie | Founding Partner and Entrepreneur in Residence | 0 | https://shizune.co/investors/profile/neill-moray-mackenzie |
| Poul Sørensen | Partner and Entrepreneur-in-Residence | 0 | https://shizune.co/investors/profile/poul-s%C3%B8rensen |
| Remi Soula | Founding Partner, Entrepreneur in Residence | 0 | https://shizune.co/investors/profile/remi-soula |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Laigo Bio | Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders. | $6.4M | Seed | Mar 23, 2026 |  |
| Enodia Therapeutics | Enodia Therapeutics is a biotech company that provides transforming treatments for cancer, inflammation, and viral infection diseases. | $24.2M | Seed | Jan 08, 2026 |  |
| Laigo Bio | Laigo Bio uses E3 ligase internalization to precisely degrade membrane proteins linked to autoimmune and inflammatory disorders. | $13.4M | Seed | Dec 03, 2025 |  |
| Elkedonia | Elkedonia is a biotech company dedicated to transforming antidepressant therapy. It aims to develop a groundbreaking antidepressant treatment that is accessible, fast-acting, and free from the risks of dependence, sedation, or psychotic effects. | $12.9M | Seed | Jun 11, 2025 |  |

4 of 4 investments shown.

## Co-investors
- [Angelini Ventures](https://shizune.co/investors/profile/angelini-ventures) — VC Fund, 3 deals together
- [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners) — VC Fund, 3 deals together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 2 deals together
- [Cancer Research Horizons](https://shizune.co/investors/profile/cancer-research-technology) — VC Fund, 2 deals together
- [Curie Capital](https://shizune.co/investors/profile/curie-capital) — VC Fund, 2 deals together
- [Eurazeo](https://shizune.co/investors/profile/eurazeo-com) — VC Fund, 2 deals together

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

## FAQ

### What does ARGOBIO invest in?

ARGOBIO invests primarily in Medical, Biotechnology and Health Care startups, most often at Seed stage. Most of the 4 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### How do I contact ARGOBIO?

Public channels for ARGOBIO include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.

### Who are the partners at ARGOBIO?

The team at ARGOBIO includes Daniel Sobral (Partner and Chief Financial Officer), Neill Moray Mackenzie (Founding Partner and Entrepreneur in Residence) and Poul Sørensen (Partner and Entrepreneur-in-Residence). The Team section lists each member with their title, investment count and links.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co